OTC •
Healthcare •
Biotechnology •
Quote as of 06/05/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.5677 mln
Float472 mln
Earnings Date05/20/2026
Piotroski F-Score
5
/ 9
Neutral
Relative Strength
27
/ 100
Underperforming
Debt / Equity
-0.32
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
Aibotics Inc. is a Miami-based company focused on developing psychedelic-based treatments for people dealing with depression and anxiety, particularly those receiving end-of-life care. Previously operating under the name Mycotopia Therapies Inc., the company adopted its current name in early 2025.
